Fabrice Le Bœuf

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index4.8kcitations68works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(42), CAR-T cell therapy research(32), Viral Infections and Outbreaks Research(17), Immune Cell Function and Interaction(13), Viral Infectious Diseases and Gene Expression in Insects(11)

Publications68 total

Supplementary Figure S1 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S5 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S5 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S6 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S6 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S3 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure Legends from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S7 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S3 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S2 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure Legends from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Data from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S1 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S4 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S2 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S4 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Supplementary Figure S7 from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Data from Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
2023Open Access
Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy
Molecular Therapy — Oncolytics·2020· 74 citedOpen Access
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
Molecular Therapy — Oncolytics·2019· 32 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

John C. Bell(42), Jean‐Simon Diallo(28), Theresa Falls(19), Harold Atkins(14), Kelley A. Parato(10), Chantal G. Lemay(10), David P. Conrad(9), Jovian Tsang(8), David H. Kirn(7), Rebecca C. Auer(7), Cory Batenchuk(7), David F. Stojdl(7), Brian D. Lichty(7), J. Andrea McCart(7), Carolina S. Ilkow(6), Rozanne Arulanandam(6), Julie A. Cox(6), Markus Vähä‐Koskela(6), Meaghan Maclean(6), Caroline J. Breitbach(5)